{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:33Z","timestamp":1792725213267,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T00:00:00Z","timestamp":1477440000000},"content-version":"vor","delay-in-days":2582,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/mt.2009.141","type":"journal-article","created":{"date-parts":[[2009,6,30]],"date-time":"2009-06-30T10:00:40Z","timestamp":1246356040000},"page":"1743-1753","source":"Crossref","is-referenced-by-count":72,"title":["Amelioration of Psoriasis by Anti-TNF-\u03b1 RNAi in the Xenograft Transplantation Model"],"prefix":"10.1016","volume":"17","author":[{"given":"Maria","family":"Jakobsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Stenderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Rosada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Moldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas N","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob Giehm","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2009.141_bib1","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/mt.2009.141_bib2","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1038\/mt.2009.141_bib3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.141_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2007.01.006","article-title":"Immunobiologics in the treatment of psoriasis","volume":"123","author":"Chong","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1038\/mt.2009.141_bib5","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/mt.2009.141_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/1568010043343868","article-title":"Immunopathogenesis of psoriasis","volume":"3","author":"Ozawa","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1038\/mt.2009.141_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","article-title":"Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy","volume":"54","author":"Markham","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2009.141_bib8","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1038\/mt.2009.141_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.49.9.665","article-title":"Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis","volume":"49","author":"Tetta","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1038\/mt.2009.141_bib10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF01540912","article-title":"Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease","volume":"16","author":"Reimund","year":"1996","journal-title":"J Clin Immunol"},{"key":"10.1038\/mt.2009.141_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4049\/jimmunol.176.3.1431","article-title":"Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2","volume":"176","author":"Johansen","year":"2006","journal-title":"J Immunol"},{"key":"10.1038\/mt.2009.141_bib12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1038\/mt.2009.141_bib13","first-page":"545","article-title":"RNA interference: the molecular immune system","volume":"35","author":"Bagasra","year":"2004","journal-title":"J Mol Histol"},{"key":"10.1038\/mt.2009.141_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1101\/gad.862301","article-title":"RNA interference is mediated by 21- and 22-nucleotide RNAs","volume":"15","author":"Elbashir","year":"2001","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2009.141_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","article-title":"Asymmetry in the assembly of the RNAi enzyme complex","volume":"115","author":"Schwarz","year":"2003","journal-title":"Cell"},{"key":"10.1038\/mt.2009.141_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.1068999","article-title":"A system for stable expression of short interfering RNAs in mammalian cells","volume":"296","author":"Brummelkamp","year":"2002","journal-title":"Science"},{"key":"10.1038\/mt.2009.141_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":"Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2009.141_bib18","doi-asserted-by":"crossref","first-page":"9742","DOI":"10.1073\/pnas.171251798","article-title":"Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems","volume":"98","author":"Caplen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.141_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1038\/mt.2009.141_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/418038a","article-title":"RNA interference in adult mice","volume":"418","author":"McCaffrey","year":"2002","journal-title":"Nature"},{"key":"10.1038\/mt.2009.141_bib21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nbt824","article-title":"Inhibition of hepatitis B virus in mice by RNA interference","volume":"21","author":"McCaffrey","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2009.141_bib22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"10.1038\/mt.2009.141_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1207","article-title":"Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS","volume":"11","author":"Raoul","year":"2005","journal-title":"Nat Med"},{"key":"10.1038\/mt.2009.141_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1089\/10430340152480276","article-title":"Sustainable systemic delivery via a single injection of lentivirus into human skin tissue","volume":"12","author":"Baek","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.141_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymthe.2003.09.016","article-title":"Lentivectors for regulated and reversible cutaneous gene delivery","volume":"9","author":"Siprashvili","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.141_bib26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1089\/104303402320987888","article-title":"Lentiviral-mediated RNA interference","volume":"13","author":"Abbas-Terki","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2009.141_bib27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1046\/j.1523-1747.1999.00811.x","article-title":"1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice","volume":"113","author":"Dam","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.141_bib28","doi-asserted-by":"crossref","first-page":"17270","DOI":"10.1073\/pnas.0406214101","article-title":"Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference","volume":"101","author":"Thakker","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2009.141_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2133.2008.08890.x","article-title":"Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model","volume":"160","author":"Stenderup","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/mt.2009.141_bib30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/mt.2009.141_bib31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2133.2004.06105.x","article-title":"Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab","volume":"151","author":"Chew","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1038\/mt.2009.141_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1568010043343903","article-title":"Targeting tumor necrosis factor-alpha in the therapy of psoriasis","volume":"3","author":"Gisondi","year":"2004","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1038\/mt.2009.141_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2004.02.021","article-title":"Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial","volume":"51","author":"Gottlieb","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2009.141_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNFalpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1038\/mt.2009.141_bib35","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1128\/JVI.76.3.1496-1504.2002","article-title":"In vivo assessment of gene delivery to keratinocytes by lentiviral vectors","volume":"76","author":"Kuhn","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2009.141_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/sj.gt.3302915","article-title":"Gene transfer in human skin with different pseudotyped HIV-based vectors","volume":"14","author":"Hachiya","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.141_bib37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","article-title":"Effective gene therapy with nonintegrating lentiviral vectors","volume":"12","author":"Y\u00e1\u00f1ez-Mu\u00f1oz","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2009.141_bib38","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5701060","article-title":"Single-nucleotide-specific siRNA targeting in a dominant-negative skin model","volume":"128","author":"Hickerson","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.141_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.jid.5701040","article-title":"Development of therapeutic siRNAs for pachyonychia congenita","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2009.141_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2008.04.003","article-title":"Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita","volume":"51","author":"Leachman","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1038\/mt.2009.141_bib41","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jgm.1091","article-title":"Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA","volume":"9","author":"Inoue","year":"2007","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2009.141_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.gt.3302868","article-title":"Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf","volume":"14","author":"Nakai","year":"2007","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2009.141_bib43","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/mt.2008.91","article-title":"Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells","volume":"16","author":"Ritprajak","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2009.141_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2006.07.035","article-title":"Gene silencing in a human organotypic skin model","volume":"348","author":"Mildner","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2009.141_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06765","article-title":"Sequence- and target-independent angiogenesis suppression by siRNA via TLR3","volume":"452","author":"Kleinman","year":"2008","journal-title":"Nature"},{"key":"10.1038\/mt.2009.141_bib46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1261\/rna.7285805","article-title":"Complete, gene-specific siRNA libraries: production and expression in mammalian cells","volume":"11","author":"Seyhan","year":"2005","journal-title":"RNA"},{"key":"10.1038\/mt.2009.141_bib47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-2836(03)00181-5","article-title":"Gene silencing by systemic delivery of synthetic siRNAs in adult mice","volume":"327","author":"S\u00f8rensen","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2009.141_bib48","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1128\/MCB.23.23.8505-8518.2003","article-title":"Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells","volume":"23","author":"Yant","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1038\/mt.2009.141_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0165-4608(95)00118-2","article-title":"Common clonal chromosome aberrations in cytokine-dependent continuous human T-lymphocyte cell lines","volume":"85","author":"Kaltoft","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/mt.2009.141_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/75568","article-title":"Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system","volume":"25","author":"Yant","year":"2000","journal-title":"Nat Genet"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616321384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T12:55:41Z","timestamp":1545137741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616321384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1525001616321384"],"URL":"https:\/\/doi.org\/10.1038\/mt.2009.141","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}